Recombinant Technologies LLC
Cheshire, CT
- UEI
- LC6JYTFEJ5N1
- CAGE
- 458Z3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1090 Meriden-Waterbury Turnpike #1, Cheshire, CT 06410, USA
- Website
- recombtech.com
- Founded
- 1998
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Quick answers
Is Recombinant Technologies LLC registered in SAM.gov?
Yes. Recombinant Technologies LLC's SAM.gov registration is active through January 7, 2027.
What is Recombinant Technologies LLC's most recent federal award?
Recombinant Technologies LLC's most recent federal grant award is Novel extracorporeal device 'amytrapper' to remove beta amyloid in alzheimer's disease (R44AG057327), from National Institute on Aging (NIH), on August 2, 2019.
On GovTribe
See Recombinant Technologies LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors